These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27651077)

  • 1. SREBP1c-CRY1 axis suppresses hepatic gluconeogenesis upon insulin.
    Jang H; Lee G; Kim JB
    Cell Cycle; 2017 Jan; 16(2):139-140. PubMed ID: 27651077
    [No Abstract]   [Full Text] [Related]  

  • 2. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
    Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
    Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
    Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
    Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1.
    Toledo M; Batista-Gonzalez A; Merheb E; Aoun ML; Tarabra E; Feng D; Sarparanta J; Merlo P; Botrè F; Schwartz GJ; Pessin JE; Singh R
    Cell Metab; 2018 Aug; 28(2):268-281.e4. PubMed ID: 29937374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
    Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
    Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic GSK3β-Dependent CRY1 Degradation Contributes to Diabetic Hyperglycemia.
    Kim YY; Jang H; Lee G; Jeon YG; Sohn JH; Han JS; Lee WT; Park J; Huh JY; Nahmgoong H; Han SM; Kim J; Pak M; Kim S; Kim JS; Kim JB
    Diabetes; 2022 Jul; 71(7):1373-1387. PubMed ID: 35476750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
    Liu Y; Deng J; Fan D
    Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
    Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
    Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystathionine γ-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.
    Guo W; Li D; You Y; Li W; Hu B; Zhang S; Miao L; Xian M; Zhu Y; Shen X
    FASEB J; 2019 Mar; 33(3):4212-4224. PubMed ID: 30526049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control.
    McCarty MF
    Med Hypotheses; 2016 Oct; 95():45-48. PubMed ID: 27692165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
    Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
    Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
    Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
    Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRY links the circadian clock and CREB-mediated gluconeogenesis.
    Hatori M; Panda S
    Cell Res; 2010 Dec; 20(12):1285-8. PubMed ID: 21124321
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of hepatic insulin sensitivity by activating signal co-integrator-2.
    Kim GH; Lee KJ; Oh GS; Yoon J; Kim HW; Kim SW
    Biochem J; 2012 Nov; 447(3):437-47. PubMed ID: 22861055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor.
    Kamei Y; Miura S; Suganami T; Akaike F; Kanai S; Sugita S; Katsumata A; Aburatani H; Unterman TG; Ezaki O; Ogawa Y
    Endocrinology; 2008 May; 149(5):2293-305. PubMed ID: 18202130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.